Gilead Sciences, Inc. Financials

Market Capitalization $115.80 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	1032.44
Forward PE	12.51
Price to Sales TTM	$4.09
Price to Book MRQ	$6.27
Enterprise to Revenue	4.67
Enterprise to EBITDA	9.48

Financial Reports as of Sep. 30, 2024

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2024-09-30
Profit Margin	0.45%
Operating Margin	41.96%
Return on Assets TTM	11.96%
Return on Equity TTM	0.56%

Income Statement

Revenue TTM	$28,298,999,808
Revenue per Share TTM	$22.70
Quarterly Revenue Growth	7.00%
Gross Profit TTM	$22,018,000,896
EBITDA	$10,482,000,000
Net Income to Common TTM	$126,000,000
Diluted EPS TTM	$0.09
Quarterly Earnings Growth YoY	-42.50%

Balance Sheet

Total Cash MRQ	$6,696,999,936
Total Cash per Share MRQ	$5.37
Total Debt MRQ	$
Total Debt to Equity MRQ	126.42
Current Ratio MRQ	1.26
Book Value per Share MRQ	$14.83

Cash Flow

Operating Cash Flow TTM	$10,021,999,616
Levered Free Cash Flow TTM	$9,078,375,424

GILD Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	1,246,269,952
Float Shares	1,243,897,952
Avg 10 Volume	7,568,470
Avg 30 Volume	None
Shares Short	25,656,042
Short Ratio	3.77
Short % of Shares	2.06%
% Held by Insiders	0.12%
% Held by Institutions	88.61%

Stock Price Summary

Beta	0.19
Fifty Two Week Low	$62.07
Fifty Two Week High	$98.90
Fifty Two Week Change	15.04%
Day 50 MA	$91.90
Day 200 MA	$78.88

Dividends and Splits

Forward Annual Dividend Rate	$3.08
Forward Annual Dividend Yield	3.31%
Trailing Annual Dividend Rate	$3.08
Trailing Annual Dividend Yield	3.31%
Payout Ratio	3400.00%
Dividend Date	2024-12-30
Ex Dividend Date	2024-12-13
Last Split Factor
Last Split Date	2013-01-28